Concealed Carry Reciprocity Act This bill establishes a federal statutory framework to regulate the carry or possession of concealed firearms across state lines. Specifically, an individual who is eligible to carry a concealed firearm in one state may carry or possess a concealed handgun (other than a machine gun or destructive device) in another state that allows its residents to carry concealed firearms. It sets forth requirements for the lawful concealed carry across state lines. The bill preempts most state and local laws related to concealed carry and establishes a private right of action for a person adversely affected by interference with a concealed-carry right established by this bill.
Mount Rushmore Protection Act This bill prohibits the use of any federal funds to alter, change, destroy, or remove any name, face, or other feature on the Mount Rushmore National Memorial in South Dakota and designates Mount Rushmore.
Veterans Cannabis Use for Safe Healing Act This bill prohibits the Department of Veterans Affairs (VA) from denying a veteran any VA benefit due to participation in a state-approved marijuana program. For veterans participating in these approved programs, the VA must ensure its health care providers (1) discuss marijuana use with such veterans and adjust treatment plans accordingly, and (2) record such use in the veterans' medical records. Under the bill, the VA shall authorize physicians and other VA health care providers to provide recommendations to veterans who are residents of states with approved programs.
Essential Medicines Strategic Stockpile Act of 2023 This bill requires the Department of Health and Human Services (HHS) to create a pilot program to test the effectiveness of acquiring, maintaining, managing, and distributing a stockpile of generic drugs at risk of shortage. To carry out the pilot program, HHS must enter into contracts for a term of up to three years with drug manufacturers, co-op or chain pharmacy warehouses, or other eligible entities to create a six-month stockpile of up to 50 types of such drugs. The bill establishes various program requirements, including annual evaluations by the Government Accountability Office.